Investigate Beneficial Effect of Herbal Tea in Jordanian Adults
herbaltea
Beneficial Effects of Herbal Tea on Lipid Profile, Insulin Resistance, CRP, CBC, Liver, and Kidney Function Tests, and Anthropometric Indices in Jordanian Adults
1 other identifier
interventional
30
1 country
1
Brief Summary
investigate beneficial effect of an herbal tea prepared from carob pulp and pods (Ceratonia siliqua), anise seed (Pimpinella Anisum L), wild thyme, green tea and eucalyptus leaves with Manuka honey (natural sweetener) on lipid profile and insulin resistance, CRP (C-reactive protein), CBC (complete blood count), liver function test, kidney function tests, inflammation and anthropometric indices in adults living in Amman Jordan
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 19, 2019
CompletedFirst Posted
Study publicly available on registry
September 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2020
CompletedSeptember 17, 2019
September 1, 2019
6 months
July 19, 2019
September 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (18)
Questionnaire
basic demographic information
1-2 weeks
Homocysteine serum level
venous blood sample for 30 candidates measured by umol/L normal range \< 12 umol/L
7 weeks pre and post intervention
Fasting blood sugar
venous blood sample for 30 candidates measured by mg/dL normal range 70-99 mg/dL
7 weeks pre and post intervention
Glycosylated Haemoglobin (HBA1C) blood
venous blood sample for 30 candidates measured by percentage normal range 4.8-5.8%
7 weeks pre and post intervention
Cholesterol serum
venous blood sample for 30 candidates measured by mg/dL normal range \<200 mg/dL
7 weeks pre and post intervention
Triglyceride serum
venous blood sample for 30 candidates measured by mg/dL normal range \<150 mg/dL
7 weeks pre and post intervention
HDL cholesterol(High density lipoprotein) serum
venous blood sample for 30 candidates measured by mg/dL normal range \>60mg/dL
7 weeks pre and post intervention
Cholesterol/HDL Ratio
venous blood sample for 30 candidates normal range \<4.0
7 weeks pre and post intervention
LDL Cholesterol (low density lipoprotein) serum
venous blood sample for 30 candidates measured by mg/dL normal range \<100mg/dL
7 weeks pre and post intervention
Protein serum
venous blood sample for 30 candidates measured by g/dL normal range 6.0-8.0g/dL
7 weeks pre and post intervention
C-Reactive Protein high sensitivity serum
venous blood sample for 30 candidates measured by mg/dL , low risk of CVD \<1.0 mg/dL
7 weeks pre and post intervention
Insulin serum
venous blood sample for 30 candidates measured by uU/ml normal range 2.6-24.9
7 weeks pre and post intervention
Cortisol Total (AM) serum
venous blood sample for 30 candidates measured by ug/dL normal range 6.02-18.4
7 weeks pre and post intervention
Tumor Necrosis Factor
venous blood sample for 30 candidates measured by pg/mL normal range upto 8.1
7 weeks pre and post intervention
8-OH-2 Desoxyyguanosine urine
Urine sample measured by micromol/mol normal range 0.1-2.4
7 weeks pre and post intervention
interleukin 1 Beta
venous blood sample for 30 candidates measured by pg/ml normal range upto 5 pg/ml
7 weeks pre and post intervention
weight
measured on inbody 770 measured by kg
7 weeks pre and post intervention
Height
measured by cm
pre intervention
Secondary Outcomes (31)
gastrointestinal symptoms questionnaire
7 weeks pre and post intervention
Creatinine serum
7 weeks pre and post intervention
Alanine Aminotransferase (ALT/GPT) serum
7 weeks pre and post intervention
Aspartate Aminotransferase (AST/GOT) serum
7 weeks pre and post intervention
Gamma-Glutamyl Transferase (GGT) serum
7 weeks pre and post intervention
- +26 more secondary outcomes
Study Arms (1)
adults aged 19-57
EXPERIMENTALadults aged 19-57 years old living in Amman Jordan, body mass index between 19-57
Interventions
herbal tea intervention for 7 weeks
Eligibility Criteria
You may qualify if:
- adults aged 19-57 years
- male to female ratio (1:1 ratio)
- BMI 19-35 kg/m2
- Currently living in Amman
- without significant apparent diseases
- Able to drink the tested herbal tea twice a day
You may not qualify if:
- Have chronic diseases such as diabetes, hypertension, cardiovascular or endocrine diseases or disabilities
- Using medical drugs and/or supplements
- Below 19 or above 57 years.
- participation in clinical trials within the last 2 months
- use of lipid-lowering drugs, or diabetic medication.
- Lactating and pregnant women will be also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ruba Musharbash
Amman, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 19, 2019
First Posted
September 17, 2019
Study Start
June 1, 2019
Primary Completion
November 30, 2019
Study Completion
January 30, 2020
Last Updated
September 17, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share